| Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism H Zhao, L Yang, J Baddour, A Achreja, V Bernard, T Moss, JC Marini, ... elife 5, e10250, 2016 | 796 | 2016 |
| A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR H Torikai, A Reik, PQ Liu, Y Zhou, L Zhang, S Maiti, H Huls, JC Miller, ... Blood, The Journal of the American Society of Hematology 119 (24), 5697-5705, 2012 | 649 | 2012 |
| Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells CJ Denman, VV Senyukov, SS Somanchi, PV Phatarpekar, LM Kopp, ... PloS one 7 (1), e30264, 2012 | 647 | 2012 |
| Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells P Kebriaei, H Singh, MH Huls, MJ Figliola, R Bassett, S Olivares, B Jena, ... The Journal of clinical investigation 126 (9), 3363-3376, 2016 | 520 | 2016 |
| Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ... JCI insight 1 (2), 2016 | 422 | 2016 |
| Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells LV Hurton, H Singh, AM Najjar, KC Switzer, T Mi, S Maiti, S Olivares, ... Proceedings of the National Academy of Sciences 113 (48), E7788-E7797, 2016 | 386 | 2016 |
| The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis F Gao, S Maiti, N Alam, Z Zhang, JM Deng, RR Behringer, C Lécureuil, ... Proceedings of the National Academy of Sciences 103 (32), 11987-11992, 2006 | 285 | 2006 |
| Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes K Gabrusiewicz, X Li, J Wei, Y Hashimoto, AL Marisetty, M Ott, F Wang, ... Oncoimmunology 7 (4), e1412909, 2018 | 271 | 2018 |
| Frequent association of β-catenin and WT1 mutations in Wilms tumors S Maiti, R Alam, CI Amos, V Huff Cancer research 60 (22), 6288-6292, 2000 | 269 | 2000 |
| Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies H Singh, MJ Figliola, MJ Dawson, H Huls, S Olivares, K Switzer, T Mi, ... Cancer research 71 (10), 3516-3527, 2011 | 228 | 2011 |
| Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells H Singh, MJ Figliola, MJ Dawson, S Olivares, L Zhang, G Yang, S Maiti, ... PloS one 8 (5), e64138, 2013 | 216 | 2013 |
| Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection PR Kumaresan, PR Manuri, ND Albert, S Maiti, H Singh, T Mi, J Roszik, ... Proceedings of the National Academy of Sciences 111 (29), 10660-10665, 2014 | 192 | 2014 |
| Genetic engineering of T cells to target HERV-K, an ancient retrovirus on melanoma J Krishnamurthy, BA Rabinovich, T Mi, KC Switzer, S Olivares, SN Maiti, ... Clinical Cancer Research 21 (14), 3241-3251, 2015 | 186 | 2015 |
| Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor DC Deniger, K Switzer, T Mi, S Maiti, L Hurton, H Singh, H Huls, ... Molecular therapy 21 (3), 638-647, 2013 | 178 | 2013 |
| piggyBac Transposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies PVR Manuri, MH Wilson, SN Maiti, T Mi, H Singh, S Olivares, MJ Dawson, ... Human gene therapy 21 (4), 427-437, 2010 | 178 | 2010 |
| Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers J Veeraraghavan, Y Tan, XX Cao, JA Kim, X Wang, GC Chamness, ... Nature communications 5 (1), 4577, 2014 | 158 | 2014 |
| Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials B Jena, S Maiti, H Huls, H Singh, DA Lee, RE Champlin, LJN Cooper PloS one 8 (3), e57838, 2013 | 140 | 2013 |
| The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor Z Jin, S Maiti, H Huls, H Singh, S Olivares, L Mátés, Z Izsvák, Z Ivics, ... Gene therapy 18 (9), 849-856, 2011 | 139 | 2011 |
| A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer SY Wu, R Rupaimoole, F Shen, S Pradeep, CV Pecot, C Ivan, ... Nature communications 7 (1), 11169, 2016 | 135 | 2016 |
| Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies DC Deniger, SN Maiti, T Mi, KC Switzer, V Ramachandran, LV Hurton, ... Clinical Cancer Research 20 (22), 5708-5719, 2014 | 126 | 2014 |
